65 related articles for article (PubMed ID: 18041880)
41. New and promising treatments for rheumatoid arthritis.
Looney RJ; Stohl W
Am J Orthop (Belle Mead NJ); 2007 Jul; 36(7 Suppl):18-23. PubMed ID: 17694190
[No Abstract] [Full Text] [Related]
42. Secondary immune deficiencies associated with biological therapeutics.
Lee SJ; Yedla P; Kavanaugh A
Curr Allergy Asthma Rep; 2003 Sep; 3(5):389-95. PubMed ID: 12906774
[TBL] [Abstract][Full Text] [Related]
43. Updated consensus statement on biological agents for the treatment of rheumatoid arthritis and other rheumatic diseases (May 2002).
Furst DE; Breedveld FC; Kalden JR; Smolen JS; Antoni CE; Bijlsma JW; Burmester GR; Cronstein B; Keystone EC; Kavanaugh A; Klareskog L
Ann Rheum Dis; 2002 Nov; 61 Suppl 2(Suppl 2):ii2-7. PubMed ID: 12379612
[No Abstract] [Full Text] [Related]
44. Rheumatoid arthritis and the era of biologic therapy.
Malaviya AP; Ostör AJ
Inflammopharmacology; 2012 Apr; 20(2):59-69. PubMed ID: 22366810
[TBL] [Abstract][Full Text] [Related]
45. Observational studies on the risk of cancer associated with tumor necrosis factor inhibitors in rheumatoid arthritis: a review of their methodologies and results.
Solomon DH; Mercer E; Kavanaugh A
Arthritis Rheum; 2012 Jan; 64(1):21-32. PubMed ID: 21898354
[No Abstract] [Full Text] [Related]
46. Cytotoxic T-lymphocyte antigen 4-immunoglobulin in rheumatoid arthritis.
Kremer JM
Rheum Dis Clin North Am; 2004 May; 30(2):381-91, viii. PubMed ID: 15172047
[TBL] [Abstract][Full Text] [Related]
47. [State-of-the-art biological therapy of rheumatoid arthritis].
Sigidin IaA; Lukina GV
Vestn Ross Akad Med Nauk; 2008; (6):19-24. PubMed ID: 18652199
[TBL] [Abstract][Full Text] [Related]
48. New strategies for patenting biological medicines used in rheumatoid arthritis treatment.
Oliveira RA; Fierro IM
Expert Opin Ther Pat; 2018 Aug; 28(8):635-646. PubMed ID: 30047807
[TBL] [Abstract][Full Text] [Related]
49. Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010.
Furst DE; Keystone EC; Braun J; Breedveld FC; Burmester GR; De Benedetti F; Dörner T; Emery P; Fleischmann R; Gibofsky A; Kalden JR; Kavanaugh A; Kirkham B; Mease P; Sieper J; Singer NG; Smolen JS; Van Riel PL; Weisman MH; Winthrop K
Ann Rheum Dis; 2011 Mar; 70 Suppl 1():i2-36. PubMed ID: 21339216
[No Abstract] [Full Text] [Related]
50. A signal achievement in the treatment of arthritis.
Cron RQ
Arthritis Rheum; 2005 Aug; 52(8):2229-32. PubMed ID: 16052533
[No Abstract] [Full Text] [Related]
51. Access to disease modifying treatments for rheumatoid arthritis patients.
Furst DE; Breedveld FC; Burmester GR; Crofford L; Emery P; Feldman M; Kalden JR; Kavanaugh A; Keystone E; Lipsky PE; Maini RN; Moreland L; Smolen JS; Van De Putte L; Vischer T; Weinblatt M; Weissman M
Ann Rheum Dis; 1999 Nov; 58 Suppl 1(Suppl 1):I129-30. PubMed ID: 10577989
[No Abstract] [Full Text] [Related]
52. Inflammation in rheumatology in 2015: New tools to tackle inflammatory arthritis.
Dinarello CA; Joosten LA
Nat Rev Rheumatol; 2016 Feb; 12(2):78-80. PubMed ID: 26763730
[No Abstract] [Full Text] [Related]
53. Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2012.
Furst DE; Keystone EC; So AK; Braun J; Breedveld FC; Burmester GR; De Benedetti F; Dörner T; Emery P; Fleischmann R; Gibofsky A; Kalden JR; Kavanaugh A; Kirkham B; Mease P; Rubbert-Roth A; Sieper J; Singer NG; Smolen JS; Van Riel PL; Weisman MH; Winthrop KL
Ann Rheum Dis; 2013 Apr; 72 Suppl 2():ii2-34. PubMed ID: 23532441
[No Abstract] [Full Text] [Related]
54. [Targeting therapy in rheumatoid arthritis].
Sugita T
Nihon Yakurigaku Zasshi; 2007 Mar; 129(3):177-81. PubMed ID: 17379968
[No Abstract] [Full Text] [Related]
55. Have the new drugs relieved the burden of the orthopedic surgeon?
Pap G; Shigeyama Y
Curr Opin Rheumatol; 2001 May; 13(3):214-8. PubMed ID: 11333351
[TBL] [Abstract][Full Text] [Related]
56. Efficacy and toxicity of old and new disease modifying antirheumatic drugs.
Tugwell P; Welch V; Suarez-Almazor M; Shea B; Wells G
Ann Rheum Dis; 2000 Nov; 59 Suppl 1(Suppl 1):i32-5. PubMed ID: 11053083
[No Abstract] [Full Text] [Related]
57. Disease-modifying anti-rheumatic drugs. Cyclosporin.
Chaudhuri K; Torley H; Madhok R
Br J Rheumatol; 1997 Sep; 36(9):1016-21. PubMed ID: 9376978
[No Abstract] [Full Text] [Related]
58. Rituximab in Graves' disease.
Rodien P
Eur J Endocrinol; 2008 Nov; 159(5):515-6. PubMed ID: 18708435
[No Abstract] [Full Text] [Related]
59. Rheumatoid arthritis.
Gay S
Curr Opin Rheumatol; 2001 May; 13(3):191-2. PubMed ID: 11333347
[No Abstract] [Full Text] [Related]
60. A new century of antirheumatic therapy.
McMurray RW
Am J Med Sci; 2002 Apr; 323(4):169-70. PubMed ID: 12003370
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
